Endocrinology. Follicular and luteal phase characteristics following early cessation of gonadotrophin-releasing hormone agonist during ovarian stimulation for in-vitro fertilization

By Beckers N.G.M.  

Human Reproduction, Vol. 15, Iss. 1, 2000-01 ,pp. : 43-49

Oxford University Press

Access to resources Recommend Favorite

Reducing the dose of gonadotrophin-releasing hormone agonist on starting ovarian stimulation: effect on ovarian response and in-vitro fertilization outcome

By Elgendy M   Afnan M  

Human Reproduction, Vol. 13, Iss. 9, 1998-09 ,pp. : 2382-2385

Oxford University Press

Access to resources Recommend Favorite

Influence of gonadotrophin-releasing hormone agonist total dose in the ovarian stimulation in the long down-regulation protocol for in-vitro fertilization

By Alvarez C.   Cremades N.   Blasco N.   Bernabeu R.  

Human Reproduction, Vol. 12, Iss. 11, 1997-11 ,pp. : 2366-2369

Oxford University Press

Access to resources Recommend Favorite

Endocrinology. Luteal support with micronized progesterone following in-vitro fertilization using a down-regulation protocol with gonadotrophin-releasing hormone agonist: a comparative study between vaginal and oral administration

By Friedler S.   Raziel A.   Schachter M.   Strassburger D.   Bukovsky I.  

Human Reproduction, Vol. 14, Iss. 8, 1999-08 ,pp. : 1944-1948

Oxford University Press

Access to resources Recommend Favorite

Histological evaluation of endometrium on the day of oocyte retrieval after gonadotrophin-releasing hormone agonist/follicle stimulating hormone ovulation induction for in-vitro fertilization

By Lass A  

Human Reproduction, Vol. 13, Iss. 11, 1998-11 ,pp. : 3203-3205

Oxford University Press

Access to resources Recommend Favorite